drugset / Trial / NCT00503412
Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Open, non-randomised, radiolabelled, single centre study with a total of six patients with solid metastatic tumors to determine the rates and routes of elimination of 14C-AZD2171 and its metabolites.
Timeline
- Start
- 2005-11
- Primary completion
- —
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cediranib | Small molecule | — | Oral |